Sore Throat Relief Spray
Pricing Report NDC 68016-342-06

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

The latest wholesale acquisition cost for Sore Throat Relief Cherry Flavor (NDC 68016-342-06) is $0.01079 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Nov 19, 2014.

As a a human over the counter drug provided by Chain Drug Consortium, this medication is distributed in a 177 mL in 1 BOTTLE, SPRAY configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.01079
Per ML

Effective Date
Nov 19, 2014
Data Status
As of Nov 19, 2014
C/I - Chain or Independent Pharmacy
Package NDC
Description
177 mL in 1 BOTTLE, SPRAY
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.01079 to $0.01329 per ML. Over this 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.0108 - $0.0133
Market Volatility
23.17% Variance
Latest Trend
12.28%
Date Unit Price Unit Source Method Rate
Nov 19, 2014 $0.01079 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 22, 2014 $0.01230 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 17, 2014 $0.01097 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 20, 2014 $0.01085 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 23, 2014 $0.01099 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 18, 2014 $0.01200 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 21, 2014 $0.01329 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 23, 2014 $0.01250 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 19, 2014 $0.01183 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Feb 19, 2014 $0.01315 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 22, 2014 $0.01106 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 18, 2013 $0.01241 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Nov 21, 2013 $0.01191 MLC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026